IT1171297B - Linea di cellule derivati da epatoma umano per studi metabolici coltivazione di virus e preparazione di vaccini e procedimento di preparazione - Google Patents

Linea di cellule derivati da epatoma umano per studi metabolici coltivazione di virus e preparazione di vaccini e procedimento di preparazione

Info

Publication number
IT1171297B
IT1171297B IT48663/81A IT4866381A IT1171297B IT 1171297 B IT1171297 B IT 1171297B IT 48663/81 A IT48663/81 A IT 48663/81A IT 4866381 A IT4866381 A IT 4866381A IT 1171297 B IT1171297 B IT 1171297B
Authority
IT
Italy
Prior art keywords
preparation
line
cells derived
human hepatoma
metabolic studies
Prior art date
Application number
IT48663/81A
Other languages
English (en)
Other versions
IT8148663A0 (it
Inventor
Barbara B Knowles
David P Aden
Original Assignee
Wistar Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Inst filed Critical Wistar Inst
Publication of IT8148663A0 publication Critical patent/IT8148663A0/it
Application granted granted Critical
Publication of IT1171297B publication Critical patent/IT1171297B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IT48663/81A 1980-06-12 1981-06-11 Linea di cellule derivati da epatoma umano per studi metabolici coltivazione di virus e preparazione di vaccini e procedimento di preparazione IT1171297B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/158,685 US4393133A (en) 1980-06-12 1980-06-12 Human hepatoma derived cell line, process for preparation thereof, and uses therefor

Publications (2)

Publication Number Publication Date
IT8148663A0 IT8148663A0 (it) 1981-06-11
IT1171297B true IT1171297B (it) 1987-06-10

Family

ID=22569250

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48663/81A IT1171297B (it) 1980-06-12 1981-06-11 Linea di cellule derivati da epatoma umano per studi metabolici coltivazione di virus e preparazione di vaccini e procedimento di preparazione

Country Status (10)

Country Link
US (1) US4393133A (it)
EP (1) EP0053165B1 (it)
JP (1) JPH0411198B2 (it)
AT (1) AT391145B (it)
CA (1) CA1193210A (it)
CH (1) CH657456A5 (it)
DE (1) DE3152113C2 (it)
GB (1) GB2089370B (it)
IT (1) IT1171297B (it)
WO (1) WO1981003663A1 (it)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721675A (en) * 1982-02-01 1988-01-26 Abbott Laboratories Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system
US4532204A (en) * 1982-07-19 1985-07-30 Massachusetts Institute Of Technology Mutation assays involving blood cells that metabolize toxic substances
US4808532A (en) * 1985-07-01 1989-02-28 The United States Of America As Represented By The United States Department Of Energy Continuous human cell lines and method of making same
FR2585722B1 (fr) * 1985-07-31 1987-11-20 Ire Celltarg Sa Co-cultures d'hepatocytes et de cellules epitheliales de foie traitees
US4966852A (en) * 1987-07-23 1990-10-30 Monsanto Company DNA clone of human tissue factor inhibitor
US5529920A (en) * 1988-12-14 1996-06-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Human liver epithelial cell line and culture media therefor
US5665589A (en) * 1988-12-14 1997-09-09 The United States Of America As Represented By The Department Of Health And Human Services Human liver epithelial cell lines
CA2081782C (en) * 1990-05-16 2004-08-24 James H. Kelly Permanent human hepatocyte cell line and its use in a liver assist device (lad)
US5704910A (en) 1995-06-05 1998-01-06 Nephros Therapeutics, Inc. Implantable device and use therefor
US5994061A (en) * 1995-09-29 1999-11-30 Queen's University At Kingston DNA constructs and methods for screening for increased expression of human apo AI gene
US5869243A (en) * 1996-03-05 1999-02-09 Rhode Island Hospital Immortalized hepatocytes
CA2453100C (fr) * 2001-07-06 2013-10-29 Institut National De La Sante Et De La Recherche Medicale (I.N.S.E.R.M.) Nouvelles lignees d'hepatomes humains, leurs obtentions et leurs applications
CA2444292A1 (en) * 2003-10-03 2005-04-03 Inserm Bipotential liver cell lines from wild-type mammalian liver tissue
WO2005071060A2 (en) * 2004-01-08 2005-08-04 North Carolina State University Methods and devices for microencapsulation of cells
JP5623004B2 (ja) * 2004-10-25 2014-11-12 ベイラー リサーチ インスティテュートＢａｙｌｏｒ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ 熱ショックをかけたメラノーマ細胞体が装填された樹状細胞
WO2007092735A2 (en) 2006-02-02 2007-08-16 Innovative Bio Therapies An extracorporeal cell-based therapeutic device and delivery system
US20090081296A1 (en) * 2006-02-02 2009-03-26 Humes H David Extracorporeal cell-based therapeutic device and delivery system
AU2009327485A1 (en) * 2008-06-18 2010-06-24 Cytopherx, Inc. Methods for propagation of renal precursor cells
KR101179171B1 (ko) 2008-08-14 2012-09-03 주식회사 운화 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물
CN103087989A (zh) * 2013-02-01 2013-05-08 湖南省肿瘤医院 一种人肝癌细胞系hlcz01及其应用
US9389220B2 (en) 2014-01-30 2016-07-12 The Cleveland Clinic Foundation In vitro assay systems and methods for identifying anti-cancer agents
US20200115682A1 (en) * 2017-04-03 2020-04-16 Deborah Lynn GREENE NGUYEN Use of Engineered Liver Tissue Constructs for Modeling Liver Disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1300391A (en) * 1969-08-22 1972-12-20 Nat Res Dev Cell lines and virus culture
DD109659A1 (it) * 1974-01-25 1974-11-12
DE2431918A1 (de) * 1974-07-03 1976-01-22 Bbc Brown Boveri & Cie Verfahren und vorrichtung zur kontinuierlichen bestimmung und auswertung der humantoxizitaet von fluessigkeiten
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro
FR2444713A1 (fr) * 1978-12-18 1980-07-18 Pasteur Institut Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant
US4209587A (en) * 1978-12-29 1980-06-24 Monsanto Company Production of tumor angiogenesis factor by cell culture
US4352880A (en) * 1979-09-17 1982-10-05 Massachusetts Institute Of Technology Diffusion bioassay for the quantitative determination of mutagenicity
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen
PT72015B (en) * 1979-11-13 1982-06-20 Merck & Co Inc Process for preparing "invitro" cultures of hepatitis b virus
EP0037330B1 (en) * 1980-03-27 1984-03-07 Merck & Co. Inc. Method of growing hepatitis b surface antigen
PT73614B (en) * 1980-09-11 1983-10-19 Merck & Co Inc Method for preparing mycoplasma-free hepatoma cell line
US4416986A (en) * 1981-01-16 1983-11-22 Merck & Co., Inc. Methods of producing HBsAg

Also Published As

Publication number Publication date
JPH0411198B2 (it) 1992-02-27
EP0053165A4 (en) 1983-03-04
JPS57500768A (it) 1982-05-06
CH657456A5 (de) 1986-08-29
DE3152113C2 (de) 1994-06-09
CA1193210A (en) 1985-09-10
WO1981003663A1 (en) 1981-12-24
IT8148663A0 (it) 1981-06-11
EP0053165B1 (en) 1987-05-06
GB2089370B (en) 1984-09-05
AT391145B (de) 1990-08-27
DE3152113T1 (de) 1982-08-12
ATA904881A (de) 1990-02-15
EP0053165A1 (en) 1982-06-09
GB2089370A (en) 1982-06-23
US4393133A (en) 1983-07-12

Similar Documents

Publication Publication Date Title
IT1171297B (it) Linea di cellule derivati da epatoma umano per studi metabolici coltivazione di virus e preparazione di vaccini e procedimento di preparazione
IT1111374B (it) Composizioni di organopolisilossani induribili contenenti esteri di titanio e procedimento per prepararle
BE867046A (fr) Nouveaux (halo-alcoxy-phenyl-amino)-carbonyl-benzamides insecticides et leurs preparation
IT1105224B (it) Protesi vascolare di struttura composita e procedimento per produrla
IT1095523B (it) Apparecchio per mantenere costante il potenziale negativo di cellule umane animali e vegetali
IT1110885B (it) Procedimento per la preparazione di derivati dello acido ftalazin-4-ilacetico e prodotto ottenuto
BE786240Q (fr) Vaccin contre l'hepatite virale et sa preparation
IT1059052B (it) Struttura e metodo per favorire la crescita di piante
IT1117187B (it) Composizione per proteggere la pelle dai raggi del sole e procedimento per la sua preparazione
IT1109228B (it) Procedimento per la preparazione di soluzioni acquose stabili derivate da poliisocianati e prodotto ottenuto
IT1109290B (it) Derivati di naftotriazoli composizioni farmaceutiche che li contengono e procedimento per prepararli
IT7950852A0 (it) Composizione per protesi dentarie eprocedimento di preparazione
IT1107555B (it) Procedimento di preparazione per liofilizzazione di vaccino meningo coccico senza degradazione della sua efficacia
IT1114720B (it) Procedimento per la preparazione di derivati di 2-fenilimmino-imidazolidine composizioni farmaceutiche che li contengono e prodotto ottenuto
FR2293218A1 (fr) Vaccin contre les oreillons et son procede de preparation
IT1066034B (it) Politriazine stabili all idrolisi e procedimento per produrle
IT8148704A0 (it) Rologici immunofluorescenti e proce linea di cellule derivate da sarco dimento di preparazione ma osteogenico umano per saggi sie
IT1118899B (it) Derivati di 2-acil-6 amminometilfenolo e procedimento per prepararli
IT7947555A0 (it) Procedimento e composizione per regolare la crescita delle piante
FR2464300B1 (fr) Preparation de souches salmonella abortus ovis et compositions de vaccins les contenant
IT1120407B (it) Procedimento per la preparazione di derivati di pirrolidincarbossaldeide e piperidincarbossaldeide e prodotto ottenuto
IT7849828A0 (it) Derivati di 24-deidrovitamina d3 eloro preparazione
IT1119754B (it) Composizione farmaceutica anticomplementare e procedimento per produrla ed applicarla
IT1111383B (it) Composizione farmaceutica antidiarroica e procedimento per prepararla
FR2338708A1 (fr) Vaccin contre la panleucopenie des felides et son procede de preparation

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970626